Non-alcoholic fatty liver disease (NAFLD) is closely related to insulin resistance, type 2
diabetes mellitus and obesity. It is considered a multisystem disease and there is a strong …

Background Non-alcoholic fatty liver disease (NAFLD) and metabolic-associated fatty liver
disease (MAFLD) shares common pathophysiological mechanisms with type 2 diabetes …

Background Nonalcoholic fatty liver disease (NAFLD) has previously been linked to several
disease states with an impact on patient outcomes. However, clinical evidence on the …

Abundant research has associated nonalcoholic fatty liver disease (NAFLD) with
atherosclerosis, but very few reports have evaluated the association between NAFLD and …

李安琪,赵玉强,赵佩然,王锐,杨婧 Page 1 , DOI:10. 3969 / j. issn. 1001 r 5256. 2023. 08. 026
代谢相关脂肪性肝病微循环障碍与微血管系统的相关性 李安琪,赵玉强,赵佩然,王锐,杨婧 黑龙江 …

Metabolic associated fatty liver disease (MAFLD) is considered a multisystem disease that
can lead to multiple extrahepatic complications, among which cardiovascular disease (CVD) …

Nonalcoholic fatty liver disease (NAFLD) is one of the leading chronic liver diseases with
increased morbidity and mortality rates for extrahepatic diseases (including cardiovascular …

Objectives: Pulmonary embolism (PE) is an important disease due to its mortality and
morbidity-related clinical conditions. Patients with a high risk of death within 30 days are …

Portal vein thrombosis (PVT) is a common complication of cirrhosis as a result of portal
hypertension and modification in the hemostatic balance. Accumulating evidence now …

Abundant research has associated nonalcoholic fatty liver disease (NAFLD) with
atherosclerosis, but very few reports have evaluated the association between NAFLD and …